115 related articles for article (PubMed ID: 11192827)
1. Two novel monoclonal antibodies against the MUC4 tandem repeat reacting with an antigen overexpressed by lung cancer.
Botti C; Seregni E; Ménard S; Collini P; Tagliabue E; Campiglio M; Vergani B; Ghirelli C; Aiello P; Pilotti S; Bombardieri E
Int J Biol Markers; 2000; 15(4):312-20. PubMed ID: 11192827
[TBL] [Abstract][Full Text] [Related]
2. Characterization of the antigen identified by Po66. A monoclonal antibody raised against a lung squamous cell carcinoma.
Martin A; Pellen P; Guitton C; Youinou P; Collet B; Desrues B; Bourel D; Dazord L; Toujas L
Cancer Immunol Immunother; 1989; 29(2):118-24. PubMed ID: 2541906
[TBL] [Abstract][Full Text] [Related]
3. Monoclonal antibodies reacting with the MUC2 mucin core protein.
Devine PL; McGuckin MA; Birrell GW; Whitehead RH; Sachdev GP; Shield P; Ward BG
Br J Cancer; 1993 Jun; 67(6):1182-8. PubMed ID: 8512804
[TBL] [Abstract][Full Text] [Related]
4. A novel monoclonal antibody-defined antigen which distinguishes human non-small cell from small cell lung carcinomas.
Sobol RE; Peters RE; Astarita RW; Hofeditz C; Masui H; Burton D; Handley HH; Glassy MC; Fairshter R; Carlo DJ
Cancer Res; 1986 Sep; 46(9):4746-50. PubMed ID: 3015395
[TBL] [Abstract][Full Text] [Related]
5. Production of monoclonal antibodies recognising the peptide core of MUC2 intestinal mucin.
Durrant LG; Jacobs E; Price MR
Eur J Cancer; 1994; 30A(3):355-63. PubMed ID: 8204359
[TBL] [Abstract][Full Text] [Related]
6. Complementary reactivities of anti-carcinoembryonic antigen and antitumor-associated glycoprotein 72 monoclonal antibodies in lung carcinomas.
Battista P; Muraro R; Mammarella S; Curia MC; Colasante A; Rosini S; Lesti G; Sacco R; French D; Frati L
Cancer Res; 1990 Nov; 50(21):6987-94. PubMed ID: 1698547
[TBL] [Abstract][Full Text] [Related]
7. Generation and characterization of anti-MUC4 monoclonal antibodies reactive with normal and cancer cells in humans.
Moniaux N; Varshney GC; Chauhan SC; Copin MC; Jain M; Wittel UA; Andrianifahanana M; Aubert JP; Batra SK
J Histochem Cytochem; 2004 Feb; 52(2):253-61. PubMed ID: 14729877
[TBL] [Abstract][Full Text] [Related]
8. Monoclonal antibodies recognizing the non-tandem repeat regions of the human mucin MUC4 in pancreatic cancer.
Jain M; Venkatraman G; Moniaux N; Kaur S; Kumar S; Chakraborty S; Varshney GC; Batra SK
PLoS One; 2011; 6(8):e23344. PubMed ID: 21886786
[TBL] [Abstract][Full Text] [Related]
9. Monoclonal antibodies specific for two different histological types of human lung carcinoma.
Saji S; Zylstra S; Schepart BS; Ghosh SK; Jou YH; Takita H; Bankert RB
Hybridoma; 1984; 3(2):119-29. PubMed ID: 6090307
[TBL] [Abstract][Full Text] [Related]
10. Mucinous bronchioloalveolar carcinomas display a specific pattern of mucin gene expression among primary lung adenocarcinomas.
Copin MC; Buisine MP; Leteurtre E; Marquette CH; Porte H; Aubert JP; Gosselin B; Porchet N
Hum Pathol; 2001 Mar; 32(3):274-81. PubMed ID: 11274635
[TBL] [Abstract][Full Text] [Related]
11. Phenotypic characterization of lung cancers in fine needle aspiration biopsies using monoclonal antibody B72.3.
Johnston WW; Szpak CA; Thor A; Schlom J
Cancer Res; 1986 Dec; 46(12 Pt 1):6462-70. PubMed ID: 3022920
[TBL] [Abstract][Full Text] [Related]
12. Human MUC4 mucin cDNA and its variants in pancreatic carcinoma.
Choudhury A; Moniaux N; Winpenny JP; Hollingsworth MA; Aubert JP; Batra SK
J Biochem; 2000 Aug; 128(2):233-43. PubMed ID: 10920259
[TBL] [Abstract][Full Text] [Related]
13. Preliminary serological and immunohistochemical evaluation of the reactivity to two monoclonal antibodies against MUC4 mucin.
Botti C; Seregni E; Saccani-Jotti G; Vecchione A; Giarnieri E; Valli C; Menard S; Tagliabue E; Bombardieri E
Int J Biol Markers; 1997; 12(4):187-9. PubMed ID: 9582610
[No Abstract] [Full Text] [Related]
14. The potential usefulness of monoclonal antibodies in the determination of histologic types of lung cancer in cytologic preparations.
Koprowska I; Zipfel SA
Acta Cytol; 1988; 32(5):675-9. PubMed ID: 2844047
[TBL] [Abstract][Full Text] [Related]
15. Reactivity of monoclonal antibodies directed against lung cancer antigens with human lung, breast and colon cancer cell lines.
Schumacher U; Mukthar D; Schenker T
Dis Markers; 1993 Dec; 11(5-6):225-37. PubMed ID: 8082312
[TBL] [Abstract][Full Text] [Related]
16. Generation of monoclonal antibodies against human lung squamous cell carcinoma and adenocarcinoma using mice rendered tolerant to normal human lung.
Hanai N; Shitara K; Yoshida H
Cancer Res; 1986 Sep; 46(9):4438-43. PubMed ID: 3731100
[TBL] [Abstract][Full Text] [Related]
17. Recognition of the polypeptide core of mucin by monoclonal antibody MUSE11 against an adenocarcinoma-associated antigen.
Hinoda Y; Nakagawa N; Ohe Y; Kakiuchi H; Tsujisaki M; Imai K; Yachi A
Jpn J Cancer Res; 1990 Dec; 81(12):1206-9. PubMed ID: 2125988
[TBL] [Abstract][Full Text] [Related]
18. Application of anti lung adenocarcinoma monoclonal antibody recognizing cytokeratin-like cytoplasmic antigen for tumor diagnosis.
Shitara K; Fujiwara K; Kusano A; Yamaguchi K; Yoshida H; Sato S; Hanai N
Anticancer Res; 1992; 12(4):1121-9. PubMed ID: 1503402
[TBL] [Abstract][Full Text] [Related]
19. Development of antibodies against p53 in lung cancer patients appears to be dependent on the type of p53 mutation.
Winter SF; Minna JD; Johnson BE; Takahashi T; Gazdar AF; Carbone DP
Cancer Res; 1992 Aug; 52(15):4168-74. PubMed ID: 1322237
[TBL] [Abstract][Full Text] [Related]
20. Antitumor effect of antibody against a SEREX-defined antigen (UOEH-LC-1) on lung cancer xenotransplanted into severe combined immunodeficiency mice.
Mizukami M; Hanagiri T; Yasuda M; Kuroda K; Shigematsu Y; Baba T; Fukuyama T; Nagata Y; So T; Ichiki Y; Sugaya M; So T; Takenoyama M; Sugio K; Yasumoto K
Cancer Res; 2007 Sep; 67(17):8351-7. PubMed ID: 17804751
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
